Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
The purpose of this FOA is to facilitate well planned clinical trials across the cancer prevention and control spectrum aimed at improving prevention/ interception, cancer-related health behaviors, screening, early detection, healthcare delivery, management of treatment-related s
About this program
The Cancer Prevention and Control Clinical Trials Planning Grant Program (R34) supports the development of clinical trials aimed at preventing and controlling cancer. This program is designed for researchers and institutions that are planning to conduct clinical trials that will contribute to the understanding and management of cancer. The grant provides funding to assist in the planning stages, ensuring that trials are well-designed and feasible before they are implemented.
Eligibility
Eligible applicants include academic institutions, nonprofit organizations, and other entities involved in cancer research. There may be specific requirements regarding the qualifications of the principal investigator and the nature of the proposed research.